|Diabetic Nephropathy References
Kidney International 61:2025-2032, 2002:
Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-ß1.
Kidney International 68:1554-1561, 2005:
Evidence linking glycated albumin to altered nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
American Journal of Physiology Renal Physiology 292:F789-795, 2007:
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV sub chain production and development of renal insufficiency.
American Journal Nephrology 31:110-116, 2010:
Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes
Biochim Biophys Acta 1830:5480-5485, 2013:
Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts
Physiological Reports 1(4), 2013, e00083
Inhibiting Amadori-modified albumin formation improves biomarkers of podocyte damage in diabetic rats